Ifosfamide 1g + Mesna Injection 2ml Amps 3’s

Indications Ifosfamide 1g + Mesna:

• Testicular cancer
• Sarcomas (soft tissue and bone)
• Lymphomas (Hodgkin’s and non-Hodgkin’s)
• Lung cancer
• Ovarian and cervical cancers
• Other solid tumors as directed by an oncologist

Administration:

• Given as an intravenous infusion under strict medical supervision.
• Dosage depends on cancer type, body surface area, and patient condition.
• Mesna is always co-administered to protect the bladder from toxic metabolites.
• Adequate hydration and frequent urination are essential during treatment.

Safety Information:

• Contraindicated in patients with known hypersensitivity to ifosfamide or mesna.
• Use with caution in patients with bone marrow suppression, kidney, or liver impairment.
• Common side effects: nausea, vomiting, hair loss, fatigue, confusion, electrolyte disturbances.
• Serious risks: myelosuppression, hemorrhagic cystitis, encephalopathy, infertility, kidney dysfunction, secondary malignancies.
• Requires regular monitoring of blood counts, kidney function, and neurological status.
• Contraception is recommended during and after treatment, as ifosfamide may harm the unborn child.

Notice:
Ifosfamide 1g + Mesna Injection is a prescription-only cytotoxic medicine. It should only be administered in a hospital or oncology center by qualified healthcare professionals.